2019 annual financial data
Coherus Oncology 2019 Operating margin
Coherus Oncology 2019 operating margin with verified reported values.
Direct answer
Operating margin was 30.27%.
Operating income was 107,768,000 USD and net income was 89,833,000 USD.
Operating cash flow was 28,355,000 USD.
Get free Coherus Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 356,071,000 USD
- Operating income
- 107,768,000 USD
- Net income
- 89,833,000 USD
- Operating cash flow
- 28,355,000 USD